Consistently, other studies showed that inhibition of NAMPT1 expression attenuated pancreatic cancer growth in vivo (37), and that NAD + kinase could be phosphoryl-activated by KRAS/PKC axis to support pancreatic cancer growth (38). This evidence concerns the gene PRRT2 and familial pancreatic carcinoma.